EUVIMEDEUVIMED entdecken
Crossref

Production and Characterization of Recombinant scFv Against Digoxin by Phage Display Technology

Behruz Alirezapour, Masoumeh Rajabibazl, Mohhamad Javad Rasaee, Kobra Omidfar

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2013

DOI: 10.1089/mab.2012.0093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2013. Verfasst von Behruz Alirezapour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cardiac glycoside digoxin is widely used for the treatment of congestive heart failure and cardiac arrhythmias. Digoxin is a highly toxic drug and consequently is routinely measured in sera of treated patients. In such cases, antibodies are required against digoxin for detection as well as detoxification purposes. To obtain recombinant single chain antibody against digoxin, RNA was extracted from spleen of BALB/c mice immunized with digoxin-BSA and converted to cDNA. The gene fragment corresponding to the variable regions of the repertoire of antibody genes were amplified by PCR. ScFv construct was generated by randomly joining individual heavy- and light-chain variable domains through gene splicing by overlapping extension PCR. Recombinant phage library expressing scFv polypeptides were produced. Phages with higher affinity toward digoxin were selected in the biopanning process. Sensitivity of produced recombinant MAb (AR85) was determined to be about 100 pg/well, while intact MAb (BBA) produced by hybridoma technology (data not shown) was reported to be around 100 pg/well too. The saturation value for recombinant scFv MAb was found to be 1000 ng/well while that for hybridoma MAb was reported to be 10 ng/well. The affinity constant of recombinant MAb (AR85) towards digoxin was also found to be around ka=3.8×10 7 M −1 while that for hybridoma MAb (BBA) was reported to be ka=2.6×10 8 M −1 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntibodies, MonoclonalAntibody AffinityBacteriophagesCell Surface Display TechniquesDNA, ComplementaryDigoxinGene AmplificationMiceMice, Inbred BALB CPeptide LibraryRNA, MessengerRecombinant ProteinsSingle-Chain Antibodies

Substanzen

Antibodies, MonoclonalDNA, ComplementaryPeptide LibraryRNA, MessengerRecombinant ProteinsSingle-Chain AntibodiesDigoxin

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Zitieren

APA

Alirezapour, B., Rajabibazl, M., Rasaee, M. J., & Omidfar, K. (2013). Production and Characterization of Recombinant scFv Against Digoxin by Phage Display Technology. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1089/mab.2012.0093

Vancouver

Alirezapour B, Rajabibazl M, Rasaee MJ, Omidfar K. Production and Characterization of Recombinant scFv Against Digoxin by Phage Display Technology. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2013. doi:10.1089/mab.2012.0093

BibTeX
@article{Alirezapour2013,
  author = {Alirezapour, Behruz and Rajabibazl, Masoumeh and Rasaee, Mohhamad Javad and Omidfar, Kobra},
  title = {Production and Characterization of Recombinant scFv Against Digoxin by Phage Display Technology},
  journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
  year = {2013},
  doi = {10.1089/mab.2012.0093}
}
Kostenlos starten →